DR. SONALI V. KUMAR
Abstract
Various treatment modalities are available for treatment of ocular tumours which include chemotherapy,laser and radiotherapy (external beam radiation therapy or brachytherapy).Brachytherapy using plaque applicator is preferred over external beam radiation therapy when the tumour is well localized as this therapy delivers radiation dose to the tumour with lower doses to normal tissue in the vicinity. However, plaque therapy is expensive and beyond the reach for many poor patients in India. Bhabha Atomic Research Centre (BARC) recently introduced an indigenous Ruthenium-106 plaque to make brachytherapy treatment available and affordable to all needy patients in India. In the present case series we report our experience using the indigenous Ru-106 plaque for the treatment of a spectrum of ocular tumours.


FP0033 : SAFETY ANDEFFICACY OFINDIGENOUSLY DEVELOPED RUTHENIUM106 EYEPLAQUE FOR BRACHYTHERAPYOF OCULARTUMOURS
Leave a Comment